Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -321.51%-65.55M | ---- | 76.86%-15.55M | ---- | -52.57%-67.2M | ---- | -1,832.53%-44.04M | ---- | 105.22%2.54M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -459.59%-2.71M | ---- | -889.80%-485K | ---- | -96.00%-49K | ---- | -108.33%-25K | ---- | ---12K |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --481K | ---- | ---- |
| Impairment and provisions: | ---- | 410.54%34.79M | ---- | -84.16%6.81M | ---- | 31.93%43.02M | ---- | 6,448.39%32.61M | ---- | -95.68%498K |
| -Impairmen of inventory (reversal) | ---- | --6.39M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 141.40%11.05M | ---- | 1,371.39%4.58M | ---- | -102.16%-360K | ---- | 3,241.97%16.64M | ---- | --498K |
| -Impairment of goodwill | ---- | --3.26M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 530.22%14.1M | ---- | -94.84%2.24M | ---- | 171.69%43.38M | ---- | --15.97M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | -135.37%-916K | ---- | --2.59M | ---- | ---- | ---- | -586.00%-10.34M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | -135.37%-916K | ---- | --2.59M | ---- | ---- | ---- | -622.64%-10.34M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.33%1K |
| Depreciation and amortization: | ---- | 32.92%3.35M | ---- | 18.47%2.52M | ---- | 50.28%2.13M | ---- | 250.50%1.42M | ---- | -83.54%404K |
| -Depreciation | ---- | 34.90%3.02M | ---- | 9.85%2.24M | ---- | 44.07%2.04M | ---- | 250.50%1.42M | ---- | -83.54%404K |
| -Amortization of intangible assets | ---- | 17.14%328K | ---- | 218.18%280K | ---- | --88K | ---- | ---- | ---- | ---- |
| Financial expense | ---- | 9.73%2.04M | ---- | -45.60%1.86M | ---- | -50.33%3.42M | ---- | 1.88%6.88M | ---- | -52.97%6.76M |
| Special items | ---- | -99.03%31K | ---- | 630.73%3.19M | ---- | --436K | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -991.36%-28.05M | ---- | 83.58%-2.57M | ---- | -484.93%-15.65M | ---- | -1,637.01%-2.68M | ---- | 99.10%-154K |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 151.67%9.34M | ---- | 265.57%3.71M | ---- | ---2.24M | ---- | ---- | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | 169.49%1.98M | ---- | -123.31%-2.84M | ---- | 122.50%12.19M | ---- | -299.59%-54.19M | ---- | 31.85%-13.56M |
| Accounts payable increase (decrease) | ---- | -167.98%-5.97M | ---- | 143.33%8.78M | ---- | -453.00%-20.27M | ---- | -59.54%5.74M | ---- | -50.52%14.19M |
| prepayments (increase)decrease | ---- | 112.26%4.54M | ---- | 10.02%-37M | ---- | 8.33%-41.12M | ---- | -49.12%-44.86M | ---- | -589.92%-30.08M |
| Special items for working capital changes | ---- | 97.16%-268K | ---- | -2,990.16%-9.43M | ---- | ---305K | ---- | ---- | ---- | -83.48%201K |
| Cash from business operations | ---- | 53.14%-18.43M | ---- | 41.62%-39.34M | ---- | 29.79%-67.39M | ---- | -226.44%-95.98M | ---- | -2,822.76%-29.4M |
| Other taxs | ---- | 11.59%-290K | ---- | ---328K | ---- | ---- | ---- | ---161K | ---- | ---- |
| Special items of business | 81.73%-572K | ---- | 87.85%-3.13M | ---- | -74.67%-25.76M | ---- | 33.02%-14.75M | ---- | -1,661.20%-22.02M | ---- |
| Net cash from operations | 81.73%-572K | 52.80%-18.72M | 87.85%-3.13M | 41.14%-39.67M | -74.67%-25.76M | 29.91%-67.39M | 33.02%-14.75M | -226.98%-96.14M | -1,661.20%-22.02M | -2,822.76%-29.4M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 8,233.33%1.5M | ---- | -63.27%18K | ---- | 96.00%49K | ---- | 108.33%25K | ---- | --12K |
| Purchase of fixed assets | ---- | 64.94%-643K | -572.53%-612K | -120.17%-1.83M | ---91K | 81.30%-833K | ---- | -20,145.45%-4.45M | ---- | 88.36%-22K |
| Purchase of intangible assets | ---- | ---- | ---- | ---152K | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of subsidiaries | ---24K | ---- | ---- | 332,700.00%3.33M | --3.65M | ---1K | ---- | ---- | ---- | -115.79%-41K |
| Acquisition of subsidiaries | ---- | ---- | ---- | 36,600.00%3.67M | ---- | 101.36%10K | ---- | ---737K | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---481K | ---- | ---- |
| Other items in the investment business | 3,700.00%38K | ---4.38M | -80.00%1K | ---- | 101.92%5K | ---- | 82.61%-260K | ---- | ---1.5M | ---- |
| Net cash from investment operations | 102.29%14K | -170.15%-3.53M | -117.14%-611K | 748.77%5.03M | 1,470.77%3.56M | 86.28%-775K | 82.61%-260K | -10,972.55%-5.65M | ---1.5M | 75.48%-51K |
| Net cash before financing | 85.08%-558K | 35.77%-22.25M | 83.14%-3.74M | 49.18%-34.64M | -47.89%-22.19M | 33.03%-68.16M | 36.18%-15.01M | -245.59%-101.79M | -1,780.80%-23.51M | -2,326.19%-29.45M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 253.26%650K | -54.17%1.38M | -93.87%184K | -57.57%3M | -74.23%3M | -91.54%7.07M | --11.64M | 334.97%83.58M | ---- | 269.54%19.22M |
| Refund | ---331K | ---8.4M | ---- | ---- | ---- | ---3.24M | ---- | ---- | ---- | -180.15%-37M |
| Issuing shares | -94.39%1.45M | -10.00%27.51M | -13.59%25.82M | -60.87%30.57M | --29.87M | --78.12M | ---- | ---- | ---- | 714.08%69.91M |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -18.92%3M |
| Interest paid - financing | ---- | 7.37%-176K | ---- | 19.49%-190K | ---- | -153.76%-236K | ---- | 69.00%-93K | ---- | 93.23%-300K |
| Issuance expenses and redemption of securities expenses | ---- | 57.01%-2.45M | ---- | -493.13%-5.69M | ---- | -18.52%-960K | ---- | ---810K | ---- | ---- |
| Other items of the financing business | 64.43%-599K | ---- | -278.43%-1.68M | ---- | -332.04%-445K | ---- | -101.87%-103K | ---- | 284.94%5.52M | ---- |
| Net cash from financing operations | -95.20%1.17M | -39.94%15.64M | -25.02%24.32M | -67.49%26.04M | 181.09%32.43M | -2.10%80.09M | 109.00%11.54M | 50.21%81.81M | 284.94%5.52M | 6,440.51%54.47M |
| Effect of rate | ---- | 99.70%-2K | 103.21%30K | -1,006.67%-664K | -3,366.67%-936K | 94.48%-60K | -109.09%-27K | -4,821.74%-1.09M | --297K | 1,050.00%23K |
| Net Cash | -97.04%610K | 23.11%-6.61M | 100.96%20.57M | -172.08%-8.6M | 395.21%10.24M | 159.71%11.93M | 80.72%-3.47M | -179.88%-19.98M | -9,877.17%-17.99M | 1,306.51%25.01M |
| Begining period cash | -98.35%111K | -57.94%6.73M | -57.94%6.73M | 288.15%15.99M | 288.15%15.99M | -83.64%4.12M | -83.64%4.12M | 16,801.34%25.18M | 16,801.34%25.18M | -93.29%149K |
| Cash at the end | -97.36%721K | -98.35%111K | 8.06%27.33M | -57.94%6.73M | 3,952.88%25.29M | 288.15%15.99M | -91.67%624K | -83.64%4.12M | 2,149.25%7.49M | 16,801.34%25.18M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhongshen Zhonghuan (Hong Kong) Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.